Alector, Inc. (ALEC): Revenue
$21.05M
Year ended 2025-12-31
$13.86M
Trailing 12 months to 2026-06-30
-46.0%
3-year compound annual growth
-0.1%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $21.05M | -79.1% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $100.56M | +3.6% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $97.06M | -27.4% | 2025-02-26, From 2023-01-01 |
| 2022-12-31 | $133.62M | -35.5% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $207.09M | +881.5% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | $21.10M | -0.6% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $21.22M | -22.9% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $27.51M | +857.8% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $2.87M | n/a | 2020-03-24, From 2017-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Alector, Inc. (ALEC) | 2025-12-31 | $21.05M | -79.1% |
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | $19.09M | n/a |
| Metagenomi Therapeutics, Inc. (MGX) | 2025-12-31 | $25.21M | -51.8% |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | $16.80M | n/a |
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | $15.36M | +53.4% |
| Scilex Holding Co (SCLX) | 2025-12-31 | $30.25M | -46.5% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $14.56M | +53.2% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $34.26M | -50.1% |
| X4 Pharmaceuticals, Inc (XFOR) | 2025-12-31 | $35.11M | n/m |
Compare ALEC, LENZ, MGX, PTHS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗